Ergovas Tablet
Marketer
A N Pharmacia
Salt Composition
Inositol nicotinate (NA)
Overview Ergovas Tablet
VascuAid tablets are prescribed for peripheral artery disease, alleviating symptoms of inadequate blood flow. The medication enhances circulation by dilating blood vessels, increasing blood delivery to affected regions. Always follow your physician's instructions for dosage; consumption may coincide with or be independent of meals, but consistent timing is recommended. Discontinuation requires medical consultation; consistent use, even during symptom remission, is crucial for long-term efficacy and preventative care. Potential side effects include vertigo, facial flushing (warmth in the face, ears, neck, and torso), cephalalgia, nausea, and emesis. Report persistent or worsening symptoms to your doctor. Prior to initiating treatment, disclose any kidney or liver conditions, pregnancy, breastfeeding, and all concurrent medications to your physician.
Primary Ingredients of Ergovas Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Ergovas Tablet
Disease affecting the body's extremities' blood vessels
Major Benefits of Ergovas Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Ergovas Tablet. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Ergovas Tablet can be administered with or without food, however, consistent timing is recommended.
Common Side effects of Ergovas Tablet:
- Dizziness
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Headache
- Nausea
- Vomiting
How to use Ergovas Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Ergovas Tablets can be administered with or without food, although consistent timing is recommended.
How Ergovas Tablet works:
Ergovas Tablets function as both a vasodilator and a lipid-reducing medication. Their mechanism involves histamine release, promoting vasodilation and the disruption of clotting factors, thereby enhancing circulation. Concurrently, they inhibit lipid synthesis, contributing to reduced cholesterol and triglyceride concentrations.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Ergovas Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Taking Ergovas Tablet during pregnancy poses a confirmed risk to the fetus. Its use should be avoided except in exceptional, life-threatening circumstances where the potential benefits outweigh the known dangers, as determined by a physician. Always seek medical advice before taking this medication.
Breast feedingUNSAFE
Lactation and Ergovas Tablet use are incompatible. Evidence indicates potential infant toxicity associated with this medication.
DrivingCONSULT YOUR DOCTOR
The effect of Ergovas Tablet on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Data regarding Ergovas Tablet use in individuals with renal impairment is scarce. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Ergovas Tablet's use in individuals with hepatic impairment. Physician consultation is recommended.
What if you forget to take Ergovas Tablet :
NA
Facts to Know About Ergovas Tablet
| Label | Value |
|---|---|
| Chemical Type | Hexacarboxylic Acid Derivative |
| Developing Habits | No. |
| Type of Therapy | HEART |
3,018 People bought this recently